Cargando…

Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan

Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue‐like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.

Detalles Bibliográficos
Autores principales: Essien, Francis, Wassem, Juakiem, Tate, Joshua, Roberts, Jared
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365551/
https://www.ncbi.nlm.nih.gov/pubmed/34430010
http://dx.doi.org/10.1002/ccr3.4645
_version_ 1783738731037982720
author Essien, Francis
Wassem, Juakiem
Tate, Joshua
Roberts, Jared
author_facet Essien, Francis
Wassem, Juakiem
Tate, Joshua
Roberts, Jared
author_sort Essien, Francis
collection PubMed
description Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue‐like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.
format Online
Article
Text
id pubmed-8365551
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83655512021-08-23 Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan Essien, Francis Wassem, Juakiem Tate, Joshua Roberts, Jared Clin Case Rep Case Report Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue‐like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug. John Wiley and Sons Inc. 2021-08-16 /pmc/articles/PMC8365551/ /pubmed/34430010 http://dx.doi.org/10.1002/ccr3.4645 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Essien, Francis
Wassem, Juakiem
Tate, Joshua
Roberts, Jared
Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title_full Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title_fullStr Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title_full_unstemmed Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title_short Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
title_sort cutaneous ulcers in association with sprue‐like enteropathy secondary to losartan
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365551/
https://www.ncbi.nlm.nih.gov/pubmed/34430010
http://dx.doi.org/10.1002/ccr3.4645
work_keys_str_mv AT essienfrancis cutaneousulcersinassociationwithspruelikeenteropathysecondarytolosartan
AT wassemjuakiem cutaneousulcersinassociationwithspruelikeenteropathysecondarytolosartan
AT tatejoshua cutaneousulcersinassociationwithspruelikeenteropathysecondarytolosartan
AT robertsjared cutaneousulcersinassociationwithspruelikeenteropathysecondarytolosartan